Therapeutics: SRA-like non-coding RNA (SLNCR); SRA-like non-coding RNA 1 (SLNCR1)

Cancer

INDICATION: Melanoma

Patient sample and cell culture studies suggest inhibiting SLNCR could help treat melanoma. In tissue

Read the full 169 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE